Nordea Investment Management AB Purchases 6,948 Shares of AngioDynamics, Inc. (ANGO)

Nordea Investment Management AB lifted its position in AngioDynamics, Inc. (NASDAQ:ANGO) by 5.8% in the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 126,040 shares of the medical instruments supplier’s stock after acquiring an additional 6,948 shares during the quarter. Nordea Investment Management AB owned 0.34% of AngioDynamics worth $2,154,000 as of its most recent SEC filing.

Other hedge funds have also recently added to or reduced their stakes in the company. Vanguard Group Inc. raised its holdings in AngioDynamics by 7.4% in the first quarter. Vanguard Group Inc. now owns 1,694,290 shares of the medical instruments supplier’s stock worth $29,396,000 after purchasing an additional 116,814 shares in the last quarter. Morgan Stanley raised its holdings in AngioDynamics by 2.0% in the first quarter. Morgan Stanley now owns 240,773 shares of the medical instruments supplier’s stock worth $4,176,000 after purchasing an additional 4,669 shares in the last quarter. Schwab Charles Investment Management Inc. raised its holdings in AngioDynamics by 67.2% in the first quarter. Schwab Charles Investment Management Inc. now owns 234,558 shares of the medical instruments supplier’s stock worth $4,070,000 after purchasing an additional 94,282 shares in the last quarter. Teachers Retirement System of The State of Kentucky raised its holdings in AngioDynamics by 77.5% in the first quarter. Teachers Retirement System of The State of Kentucky now owns 7,100 shares of the medical instruments supplier’s stock worth $123,000 after purchasing an additional 3,100 shares in the last quarter. Finally, State of Alaska Department of Revenue raised its holdings in AngioDynamics by 91.7% in the second quarter. State of Alaska Department of Revenue now owns 6,768 shares of the medical instruments supplier’s stock worth $109,000 after purchasing an additional 3,238 shares in the last quarter. Hedge funds and other institutional investors own 95.29% of the company’s stock.

AngioDynamics, Inc. (NASDAQ ANGO) opened at $17.01 on Thursday. AngioDynamics, Inc. has a fifty-two week low of $14.80 and a fifty-two week high of $18.85. The company has a current ratio of 2.34, a quick ratio of 1.48 and a debt-to-equity ratio of 0.17. The stock has a market cap of $620.13, a PE ratio of 24.48, a PEG ratio of 1.73 and a beta of 1.04.

AngioDynamics (NASDAQ:ANGO) last posted its quarterly earnings data on Thursday, September 28th. The medical instruments supplier reported $0.12 earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.16 by ($0.04). AngioDynamics had a net margin of 1.64% and a return on equity of 4.83%. The company had revenue of $85.40 million for the quarter, compared to analyst estimates of $86.12 million. During the same quarter last year, the company earned $0.17 EPS. The business’s revenue was down 3.1% compared to the same quarter last year. sell-side analysts forecast that AngioDynamics, Inc. will post 0.65 EPS for the current year.

A number of equities analysts have commented on ANGO shares. BidaskClub upgraded shares of AngioDynamics from a “sell” rating to a “hold” rating in a report on Saturday, August 19th. Zacks Investment Research upgraded shares of AngioDynamics from a “sell” rating to a “hold” rating in a report on Monday, August 14th. KeyCorp reiterated a “hold” rating on shares of AngioDynamics in a report on Friday, September 29th. Finally, Canaccord Genuity reiterated a “hold” rating and issued a $17.00 target price on shares of AngioDynamics in a report on Sunday, October 8th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the stock. AngioDynamics presently has an average rating of “Hold” and an average price target of $18.60.

ILLEGAL ACTIVITY WARNING: “Nordea Investment Management AB Purchases 6,948 Shares of AngioDynamics, Inc. (ANGO)” was originally published by Community Financial News and is the property of of Community Financial News. If you are accessing this report on another domain, it was illegally stolen and republished in violation of international copyright legislation. The correct version of this report can be read at https://www.com-unik.info/2017/12/07/nordea-investment-management-ab-purchases-6948-shares-of-angiodynamics-inc-ango.html.

AngioDynamics Profile

AngioDynamics, Inc designs, manufactures and sells a range of medical, surgical and diagnostic devices used by professional healthcare providers for vascular access, for the treatment of peripheral vascular disease and for use in oncology and surgical settings. The Company’s devices are used in minimally invasive, image-guided procedures.

Institutional Ownership by Quarter for AngioDynamics (NASDAQ:ANGO)

What are top analysts saying about AngioDynamics Inc.? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for AngioDynamics Inc. and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit